Company
Sartorius Stedim Biotech SA
Headquarters: Aubagne, France
Employees: 10,409
CEO: Dr. Joachim Kreuzburg
Market Cap
€19.82 Billion
EUR as of Jan. 1, 2025
US$20.62 Billion
Sartorius Stedim Biotech SA Categories
France Healthcare Medical Instruments & SuppliesFrance Healthcare France Medical Instruments & Supplies
Top Competitors by Market Capitalization
Industry: Medical Instruments & Supplies
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $216.79 B |
| EssilorLuxottica SA | $116.96 B |
| Becton, Dickinson and Company | $69.74 B |
| HOYA Corp | $45.26 B |
| Alcon Inc. | $41.55 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | €2.74 B |
| EBITDA | €579.5 M |
| Gross Profit TTM | €1.19 B |
| Profit Margin | 5.87% |
| Operating Margin | 10.79% |
| Quarterly Revenue Growth | -1.70% |
Stocks & Indices
Sartorius Stedim Biotech SA has the following listings and related stock indices.
Stock: Euronext: DIM wb_incandescent
Stock: FSX: 56S1 wb_incandescent